Non- Invasive Initiation & Monitoring of Resmetirom (RT) Therapy Using LIVERFASt, FIB-4, and VCTE in MASH Patients
The poster presents a retrospective study on the use of non-invasive tests (NITs) to initiate and monitor Resmetirom
Application of LIVERFASt to Predict Steatosis in Chronic Hepatitis B Patients with Metabolic Syndrome
Aims for the study: To evaluate the prognostic values of LIVERFASt as a noninvasive biomarker in detecting hepatic
Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease
Aim: This study evaluates the diagnostic performance of the novel blood-based device, LIVERFASt to detect...